Detalhe da pesquisa
1.
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.
Blood
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551812
2.
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
Blood
; 129(16): 2233-2245, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096095
3.
Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis.
Cancer Immunol Immunother
; 65(1): 13-24, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559812
4.
A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation.
Br J Haematol
; 169(1): 36-43, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572917
5.
Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.
J Immunol
; 190(3): 1360-71, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293352
6.
Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.
Blood
; 119(13): 3142-50, 2012 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267603
7.
Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15.
Blood Adv
; 7(1): 9-19, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882498
8.
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.
Front Oncol
; 13: 1271807, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111533
9.
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.
Blood
; 115(14): 2827-34, 2010 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965618
10.
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
Blood
; 115(26): 5385-92, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20395418
11.
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.
Leukemia
; 36(1): 138-154, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290359
12.
Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer.
Clin Cancer Res
; 28(21): 4820-4831, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921526
13.
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
Lancet Haematol
; 9(2): e143-e161, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114152
14.
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance.
Blood
; 114(15): 3276-84, 2009 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19587378
15.
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
Blood
; 114(2): 371-9, 2009 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19417213
16.
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
Proc Natl Acad Sci U S A
; 105(4): 1285-90, 2008 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18202175
17.
CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways.
Oncotarget
; 12(24): 2323-2337, 2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853656
18.
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma.
Commun Biol
; 4(1): 617, 2021 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031527
19.
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Blood Cancer J
; 11(10): 166, 2021 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625538
20.
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
Blood Cancer Discov
; 2(5): 468-483, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568832